BLTE

Belite Bio, Inc. ADR

BLTE·07782B104·US·ADR·Healthcare - Biotechnology-13D/G

BLTE (Belite Bio, Inc. ADR) is held by 43 institutional investors as of Q2 2026. Largest holders: RTW INVESTMENTS, LP ($110.2M), MILLENNIUM MANAGEMENT LLC ($76.2M), MAVERICK CAPITAL LTD ($61M). Net institutional sentiment: Mixed.

43
Holders
(3 Elite)
$509.5M
Total Value
54% (48)
Consensus
26 buying - 22 selling
13F: Insider & Congress: Updated regularly
BLTE

Smart Money Verdict

View all
Loading verdict
Held by 43 funds
3 elite

Who's Trading

Source dates: Price Sep 9, 2026 · Insiders Sep 9, 2026 · Activists May 14, 2026 · Congress none

InsiderLYLin Yu-HsinSell $535KSep 8, 2026
InsiderLYLin Yu-HsinSell $1.7MSep 8, 2026
InsiderCHChuang Hao-YuanSell $427KSep 8, 2026
Checking access…

Top Holders

Checking access…
Action
Unchanged
715,332$110.2M0.9%+57.49%
0
Decreased
494,564(-13.3%)$76.2M0.0%+22.24%
0
New
396,311$61M0.5%+25.24%
58
Decreased
251,035(-49.2%)$38.7M0.1%+15.70%
0
Increased
235,071(+16.7%)$36.2M0.0%+18.26%
34
Decreased
224,989(-70.7%)$34.6M0.0%+16.62%
0
Increased
186,168(+9171.3%)$28.7M0.0%+26.09%
46
Increased
166,188(+57.5%)$25.6M0.0%+21.32%
41
Increased
124,783(+3202.9%)$19.2M0.0%+25.72%
46
Increased
65,801(+438.4%)$10.1M0.0%+24.22%
45
Increased
57,125(+75.6%)$8.8M0.0%+22.32%
42
Increased
55,763(+7.2%)$8.6M0.0%+15.52%
30
New
51,186$7.9M0.0%+25.24%
38
Increased
49,516(+228.5%)$7.6M0.0%+21.89%
44
New
38,100$5.9M0.0%+25.24%
38
Increased
33,181(+11.1Kx)$5.1M0.0%+25.25%
44
New
31,721$4.9M0.0%+25.24%
37
Increased
22,640(+117.1%)$3.5M0.0%+79.58%
43
New
20,000$3.1M0.0%+25.24%
37
Decreased
15,924(-0.8%)$2.5M0.0%+191.96%
0

Showing 1-20 of 51

1 / 3
BLTEBLTEBelite Bio, Inc. ADR

Other Healthcare stocks held by institutions

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used